Antimicrobial stewardship

American Journal of Infection Control

Volumn 34, Issue 5 SUPPL., 2006, Pages

  Fishman, Neil ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; CLINDAMYCIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE; COMPUTER AIDED DESIGN; DIARRHEA; DRUG COST; DRUG INDUSTRY; GRAM NEGATIVE BACTERIUM; HEALTH CARE; HEALTH CARE COST; HUMAN; INFECTION SENSITIVITY; NONHUMAN; SPECIES DIFFERENCE; UNITED STATES;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; HUMANS; PHARMACY AND THERAPEUTICS COMMITTEE; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS;

EID: 33745238716     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2006.05.237     Document Type: Article

References (43)

1. Reimann H.A., and for the Canadian Bacterial Surveillance Network. The misuse of antimicrobics. Med Clin North Am 45 (1961) 849-856
2. Chen D.K., McGeer A., de Azavedo J.C., and Low D.E. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 341 (1999) 233-239
3. Payne D., and Tomasz A. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Curr Opin Microbiol 7 (2004) 435-438
4. Thomson C.J., Power E., Ruebsamen-Waigmann H., and Labischinski H. Antibacterial research and development in the 21st century-an industry perspective of the challenges. Curr Opin Microbiol 7 (2004) 445-450
5. Shlaes D.M., Gerding D.N., John Jr. J.F., et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25 (1997) 584-599
6. Weber J.T., and Courvalin P. An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis 11 (2005) 791-793
7. Gonzales R, Malone DC, Maselli JH, MA. Sande Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001;33:757-62.
8. Marr J.J., Moffet H.L., and Kunin C.M. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 157 (1988) 869-876
9. Reimann H.A., and D'Ambola J. The use and cost of antimicrobics in hospitals. Arch Environ Health 13 (1966) 631-636
10. Kislak J.W., Eickhoff T.C., and Finland M. Hospital-acquired infections and antibiotic usage in the Boston City Hospital-January, 1964. N Engl J Med 271 (1964) 834-835
11. Office of Technology Assessment USC. Impacts of antibiotic-resistant bacteria. OTA-H-629 (1995), Government Printing Office, Washington, DC
12. Paskovaty A., Pflomm J.M., Myke N., and Seo S.K. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. Int J Antimicrob Agents 25 (2005) 1-10
13. John Jr. J.F., and Fishman N.O. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 24 (1997) 471-485
14. Gross P.A., and Pujat D. Implementing practice guidelines for appropriate antimicrobial usage: a systematic review. Med Care 39 (2001) II55-II69
15. Evans R.S., Pestotnik S.L., Classen D.C., et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 338 (1998) 232-238
16. Pestotnik S.L., Classen D.C., Evans R.S., and Burke J.P. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 124 (1996) 884-890
17. Crowe H.M., and Quintiliani R. Antibiotic formulary selection. Med Clin North Am 79 (1995) 463-476
18. McGowan Jr. J.E., and Finland M. Usage of antibiotics in a general hospital: effect of requiring justification. J Infect Dis 130 (1974) 165-168
19. Coleman R.W., Rodondi L.C., Kaubisch S., Granzella N.B., and O'Hanley P.D. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 90 (1991) 439-444
20. Frank M.O., Batteiger B.E., Sorensen S.J., et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care 5 (1997) 180-188
21. Brown E.M., and Nathwani D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 55 (2005) 6-9
22. Masterton R.G. Antibiotic cycling: more than it might seem?. J Antimicrob Chemother 55 (2005) 1-5
23. Gerding D.N., and Larson T.A. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center. Am J Med 79 (1985) 1-7
24. Young E.J., Sewell C.M., Koza M.A., and Clarridge J.E. Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci 290 (1985) 223-227
25. Raymond D.P., Pelletier S.J., Crabtree T.D., et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 29 (2001) 1101-1108
26. Bergstrom C.T., Lo M., and Lipsitch M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A 101 (2004) 13285-13290
27. Magee J.T. The resistance ratchet: theoretical implications of cyclic selection pressure. J Antimicrob Chemother 56 (2005) 427-430
28. Sintchenko V., Coiera E., Iredell J.R., and Gilbert G.L. Comparative impact of guidelines, clinical data, and decision support on prescribing decisions: an interactive Web experiment with simulated cases. J Am Med Inform Assoc 11 (2004) 71-77
29. Evans R.S., Pestotnik S.L., Classen D.C., and Burke J.P. Evaluation of a computer-assisted antibiotic-dose monitor. Ann Pharmacother 33 (1999) 1026-1031
30. Evans R.S., Classen D.C., Pestotnik S.L., Lundsgaarde H.P., and Burke J.P. Improving empiric antibiotic selection using computer decision support. Arch Intern Med 154 (1994) 878-884
31. Evans R.S., Pestotnik S.L., Classen D.C., and Burke J.P. Development of an automated antibiotic consultant. MD Comput 10 (1993) 17-22
32. Schiff G.D., and Rucker T.D. Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA 279 (1998) 1024-1029
33. Counts G.W. Review and control of antimicrobial usage in hospitalized patients: a recommended collaborative approach. JAMA 238 (1977) 2170-2172
34. Edelstein PE, for the Hospital of the University of Pennsylvania. Guidelines for antibiotic therapy at the Hospital of the University of Pennsylvania, 2006 edition: official guidelines for antibiotic therapy, including current susceptibility data, empiric therapy, prophylaxis, dosing in renal failure, cost of antibiotics, links to other relevant sites, clinical microbiology information, and other useful information. Available at: http://www.uphs.upenn.edu/bugdrug. Accessed 2006.
35. Gross R., Morgan A.S., Kinky D.E., Weiner M., Gibson G.A., and Fishman N.O. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 33 (2001) 289-295
36. Kinky DE, Gross R, Morgan AS, Gibson GA, Fishman NO. Clinical and economic outcomes of a comprehensive antimicrobial management program. Presented at the 36th Annual Meeting of the Infectious Diseases Society of America; 1998 Nov 12-15; Denver, CO; 1998.
37. Carling P., Fung T., Killion A., Terrin N., and Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 24 (2003) 699-706
38. Khan R., and Cheesbrough J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. J Hosp Infect 54 (2003) 104-108
39. Climo M.W., Israel D.S., Wong E.S., Williams D., Coudron P., and Markowitz S.M. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 128 (1998) 989-995
40. McNulty C., Logan M., Donald I.P., et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother 40 (1997) 707-711
41. Pear S.M., Williamson T.H., Bettin K.M., Gerding D.N., and Galgiani J.N. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 120 (1994) 272-277
42. de Man P., Verhoeven B.A., Verbrugh H.A., and Vos M.C. van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355 (2000) 973-978
43. Meyer K.S., Urban C., Eagan J.A., Berger B.J., and Rahal J.J. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119 (1993) 353-358